Part of the PRO EXO Professional Series — clinical-grade exosome vials for hair transplant surgeons, dermatologists, and aesthetic clinics.
A clinic can select the perfect growth vial and still get a disappointing result if the scalp it is applied to is inflamed, greasy, flaking, or reactive. The scalp is the soil; the follicle is the plant. A large share of the hair-loss caseload arrives with a compromised scalp environment — excess sebum, seborrhoea, sensitivity, a disrupted barrier — that both contributes to the presenting complaint and quietly sabotages whatever treatment follows. A clinic offering considered seborrhoeic and oily scalp clinic treatment restores that environment first, then treats hair on a scalp that can actually support it.
This is one of the most under-appreciated levers in a hair service. Growth vials, medical therapy, even transplantation are all applied to the scalp surface — and if that surface is hostile, results suffer regardless of how good the active is. Getting the environment right is not a cosmetic afterthought; it is a clinical precondition.
This guide covers the scalp-environment indications for a clinical audience. It assumes a professional setting and is not a substitute for individual medical judgement; true seborrhoeic dermatitis, in particular, is a medical condition whose primary management (including antifungal and anti-inflammatory therapy) belongs with the treating clinician.
Why the scalp environment matters for hair
Three interacting factors make a scalp hostile to hair: sebaceous overactivity, an impaired barrier, and low-grade inflammation. They rarely occur in isolation. Excess sebum changes the surface lipid film and feeds Malassezia, the commensal yeast implicated in seborrhoea; the resulting irritation and scale disrupt the barrier; and a disrupted barrier drives water loss, sensitivity, and further inflammation. It is a self-reinforcing loop, and the follicle sits in the middle of it.
For hair specifically, this matters in two ways. First, a chronically inflamed, greasy, or scaling scalp can aggravate shedding and undermine follicular function directly. Second — and this is the part clinics most often miss — an unhealthy environment blunts every other treatment. A regeneration vial applied to an inflamed, scaly surface is working against the tissue; a patient who cannot tolerate a device pass because the scalp is raw and reactive cannot receive the treatment properly; and a transplant placed into an unmanaged seborrhoeic field faces a harder recovery.
Addressing the environment, then, is not a detour from hair treatment. It is frequently the step that makes the rest of the plan work — and skipping it is a common, invisible reason otherwise good protocols underperform.
Read the scalp, not just the hair
The clinical starting point is to characterise the environment before choosing a treatment. In practice that means reading four things: the sebum level and its distribution (frontal and vertex vs diffuse); the nature of any flaking (fine dry scale vs greasy, yellowish, adherent scale); erythema and its pattern; and the patient’s reported sensitivity, itch, and reactivity. Trichoscopy adds detail here — perifollicular scaling, erythema, and the sebaceous state are all visible — and helps separate a simple environmental problem from an early scarring process that needs referral.
The key differentials are practical. A simple oily scalp is sebum-dominant without marked inflammation. Seborrhoeic dermatitis layers Malassezia, sebum, and inflammation together — greasy yellow scale, erythema, itch — and warrants proper medical management. A dry, barrier-compromised, sensitive scalp is the opposite lipid picture: fine scale, tightness, reactivity, often iatrogenic (over-washing, harsh products). Naming which of these dominates is what tells you which vial to reach for first. The microbiome is part of this picture too — explored in our scalp microbiome guide — but the actionable clinic decision is which environmental driver to address first.
The three drivers and the AZOLEI vials
Ossome’s AZOLEI line is the scalp-environment part of the PRO EXO system — formulated to restore a calmer, more balanced surface so the rest of the plan can work. Each in-clinic vial maps to one of the main drivers:
AZOLEI PRO EXO Sebo Core — for the sebum-driven, oily, or seborrhoeic scalp. It targets sebaceous over-activity and the microbiome imbalance that rides with it, calming the greasy, scale-prone surface that unsettles both hair and treatment.
AZOLEI PRO EXO Hyper Relief — for the reactive, itching, sensitive scalp. Where pruritus, neurogenic itch, and localised dermatitis dominate, relief and calming come first, before any stimulation is attempted.
AZOLEI PRO EXO Epi New — for epithelial turnover and barrier renewal. It supports the surface where scaling, barrier dysfunction, and impaired turnover are the issue, restoring a healthier baseline for the follicle to grow from.
One primary vial — combine only when conditions coexist
The vials are drug-free biologics (3 ml, single-use, opened immediately prior to use), which makes them straightforward to layer without the constraints of a fixed formulation. The clinical rule from the usage guidelines is deliberate: select one primary vial for the dominant condition, and combine additional vials only when multiple pathologies are genuinely present. This is the modular logic that separates a matched treatment from a one-size-fits-all vial — you treat what is actually there.
| Presentation | Vials |
|---|---|
| Oily / seborrhoeic scalp | Sebo Core |
| Itchy / sensitive scalp | Hyper Relief |
| Flaky dandruff with redness (seborrhoeic dermatitis) | Sebo Core + Epi New |
| Folliculitis / scalp acne | Sebo Core + Super Recovery |
| Chronic itch / eczema-prone | Hyper Relief + Epi New |
| Fibrotic / aging scalp | Epi New + Collagen Shield |
A framework from the PRO EXO usage guidelines, not a fixed prescription. Adapt to the clinical presentation.
When hair loss and scalp problems coexist
The most common real-world case is not a pure scalp problem or a pure hair problem, but both at once — an androgenetic patient who is also seborrhoeic, or a stressed young scalp that is oily and shedding. This is exactly where a segmented, modular range earns its place. The guidelines make the logic explicit: androgenetic alopecia with seborrhoeic dermatitis is treated as Gen Men (or Fem) plus Sebo Core — the growth base for the follicle, the environment base for the surface, in the same protocol.
A single generic exosome vial cannot do this. It treats the seborrhoeic-and-balding scalp with the same product as the calm-and-balding scalp, and hopes. A range that lets the clinic name the two problems and address each with the right base is both more effective and more defensible in the consultation — the patient can be told precisely why they are receiving two vials rather than one.
Homecare between sessions
In-clinic vials reset the environment; homecare holds it. Scalp-environment problems are day-to-day problems — sebum returns, barriers are challenged by washing and styling, seborrhoea recurs — so the AZOLEI homecare line (Pure Relief Shampoo and Purifying Scalp Essence) maintains the surface between visits for oily, flaking, and sensitive scalps. Integrating homecare with the in-clinic protocol is not an upsell; it is what keeps the environment stable long enough for growth treatment to take hold, and it turns a series of procedures into a managed, continuing service.
Sequence: environment first, then growth
The workable order mirrors the rest of the Ossome system, which sequences treatment to the scalp’s state rather than applying one vial throughout. Restore the environment first — control sebum, calm inflammation, rebuild the barrier — then, once the surface is healthy, layer in growth or recovery treatment as indicated: MINOX for androgenetic growth, KERAPAIR for barrier and structural repair. Where an androgenetic and a seborrhoeic component co-exist, the clinic addresses both, often pairing an AZOLEI vial with the growth base from the outset. The principle is consistent: a calm, balanced scalp is what lets a growth vial deliver, and treating in the wrong order wastes both.
Managing expectations
Scalp-environment issues are frequently chronic and relapsing — seborrhoea especially waxes and wanes with season, stress, and hormones — so patients should understand from the start that this is managed, not cured, and that maintenance matters. Where true seborrhoeic dermatitis is present, the AZOLEI range supports the environment alongside, not instead of, the medical management the condition needs; the clinic’s role is to co-manage the surface, not to replace antifungal or anti-inflammatory therapy where that is indicated. Framed honestly, this is a service patients stay with, because the scalp genuinely feels and looks better between and beyond the hair result.
Frequently asked questions
Does treating the scalp environment actually help hair growth? Indirectly, and importantly. A calmer, less inflamed, better-barriered scalp is a better environment for the follicle and for any growth treatment applied to it. The environment work is a precondition and a multiplier, not a growth treatment in itself.
Can AZOLEI be used at the same time as a growth vial? Yes — where a scalp problem coexists with hair loss, the environment vial is combined with the growth base (for example Gen Men + Sebo Core). Select one primary vial for the dominant condition and add a second only when a distinct second pathology is present.
Is this a treatment for seborrhoeic dermatitis? No. Seborrhoeic dermatitis is a medical condition needing appropriate management. AZOLEI supports the scalp environment alongside that care; it does not replace antifungal or anti-inflammatory therapy where indicated.
How is the range different from a generic exosome? It is segmented by the actual driver — sebum, itch/sensitivity, barrier/turnover — and can be combined for coexisting conditions, so the clinic matches the vial to the presentation rather than applying one formula to everyone.
Managing scalp-environment cases?
AZOLEI PRO EXO is plant-derived and clinic-exclusive across Malaysia, Singapore, and Indonesia. Enquire via WhatsApp for documentation and protocol guidance.
Enquire on WhatsApp → View Before & After Cases